The genes differing between the cases and controls included APOE, a very well-established AD risk gene that was found to be expressed lower in patient-derived cells, and others previously linked to AD (CD2AP, RBFOX1, TMEM132C, NPAS2). This evidence concerns the gene RBFOX1 and Alzheimer disease.